FI931251L - Farmaceutiska foereningar - Google Patents

Farmaceutiska foereningar Download PDF

Info

Publication number: FI931251L
Authority: FI; Finland
Prior art keywords: pharmaceutical associations; associations; pharmaceutical
Prior art date: 1992-03-24

Application number

FI931251A

Other languages

English (en)

Other versions

FI931251A0 (fi

Inventor

Lynn Stacy Gossett

Chuan Shih

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-03-24

Filing date

1993-03-22

Publication date

1993-09-25

1993-03-22 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1993-03-22 Publication of FI931251A0 publication Critical patent/FI931251A0/fi

1993-09-25 Publication of FI931251L publication Critical patent/FI931251L/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Hematology (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

FI931251A 1992-03-24 1993-03-22 Farmaceutiska foereningar FI931251L (fi)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/856,611 US5196424A (en)	1992-03-24	1992-03-24	N-[2-amino-4-substituted[[(pyrrollo or pyrido)[2,3-d]pyrimidinyl]-alkyl]benzoyl]-L-glutamic acids

Publications (2)

Publication Number	Publication Date
FI931251A0 FI931251A0 (fi)	1993-03-22
FI931251L true FI931251L (fi)	1993-09-25

Family

ID=25324069

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI931251A FI931251L (fi)	1992-03-24	1993-03-22	Farmaceutiska foereningar

Country Status (18)

Country	Link
US (1)	US5196424A (fi)
EP (1)	EP0567223A1 (fi)
JP (1)	JPH0625246A (fi)
KR (1)	KR930019676A (fi)
CN (1)	CN1078235A (fi)
AU (1)	AU3542993A (fi)
BR (1)	BR9301273A (fi)
CA (1)	CA2091978A1 (fi)
CZ (1)	CZ44093A3 (fi)
FI (1)	FI931251L (fi)
HU (1)	HUT70036A (fi)
IL (1)	IL105100A0 (fi)
MX (1)	MX9301544A (fi)
MY (1)	MY131322A (fi)
NO (1)	NO931008L (fi)
NZ (1)	NZ247193A (fi)
TW (1)	TW224098B (fi)
ZA (1)	ZA931944B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5457056A (en) *	1993-07-06	1995-10-10	Fiberchem, Inc.	Halohydrocarbon sensing chemistry with base modifier
US6537999B2 (en) *	1996-06-06	2003-03-25	Duquesne University Of The Holy Ghost	Pyrimidine derivatives and methods of making and using these derivatives
AU4163197A (en) *	1996-08-30	1998-03-19	Eli Lilly And Company	Nonclassical pyrrolo{2,3-d}pyrimidine antifolates
WO2003009815A2 (en)	2001-07-25	2003-02-06	Biomarin Pharmaceutical Inc.	Compositions and methods for modulating blood-brain barrier transport
US8030319B2 (en)	2005-02-10	2011-10-04	Duquesne University Of The Holy Ghost	Methods for treating cancer and other pathological proliferating disorders by inhibiting mitosis using pyrrolo[2 3-d]pyrimidines
DK1889198T3 (da)	2005-04-28	2015-02-09	Proteus Digital Health Inc	Farma-informatiksystem
CN1962658B (zh) *	2005-11-10	2010-05-12	北京大学	一种四氢吡啶并[3,2-d]嘧啶类化合物及制备抗肿瘤药物的用途
KR20090071598A (ko)	2006-09-18	2009-07-01	랩터 파마슈티컬 인코포레이티드	수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
NZ594310A (en)	2009-02-20	2014-02-28	To Bbb Holding B V	Glutathione-based drug delivery system
KR20180114970A (ko)	2009-05-06	2018-10-19	라보라토리 스킨 케어, 인크.	활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
AU2010315152A1 (en) *	2009-11-06	2012-06-14	Chelsea Therapeutics, Inc.	Enzyme inhibiting compounds
US20120077778A1 (en)	2010-09-29	2012-03-29	Andrea Bourdelais	Ladder-Frame Polyether Conjugates
CN102977107B (zh) *	2012-12-25	2015-04-22	山西普德药业股份有限公司	一种培美曲塞二钠化合物及其组合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS59170091A (ja) *	1983-03-17	1984-09-26	Takeda Chem Ind Ltd	６−チオ−７−デアザプリン誘導体およびその製造法
EP0119591B1 (en) *	1983-03-17	1988-06-22	Takeda Chemical Industries, Ltd.	Thiodeazapurine derivatives
JPS61500845A (ja) *	1983-12-27	1986-05-01	エス・ア−ル・アイ・インタ−ナシヨナル	８，１０―ジデアザミノプテリン及び抗白血病剤組成物
US4684653A (en) *	1985-03-08	1987-08-04	The Trustees Of Princeton University	Pyrido(2,3-d)pyrimidine derivatives
ZA861235B (en) *	1985-03-08	1986-10-29	Univ Princeton	Pyrido(2,3-d)pyrimidine derivatives
US5026851A (en) *	1985-03-08	1991-06-25	The Trustees Of Princeton University	Pyrido[2,3-]pyrimidine derivatives
US4927828A (en) *	1985-03-08	1990-05-22	The Trustees Of Princeton University	Diastereoisomeric tetrahydropyrido-(2,3,d) pyrimidine derivatives
US4988702A (en) *	1986-08-26	1991-01-29	Warner-Lambert Company	Novel 9-deazaguanines
US4923872A (en) *	1986-08-26	1990-05-08	Warner-Lambert Co.	Analogues of pyrrolo[3,2d]pyrimidin-4-ones
US4988813A (en) *	1986-10-20	1991-01-29	The Trustees Of Princeton University	Process for the preparation of fused pyridine compounds
US4902796A (en) *	1986-10-20	1990-02-20	The Trustees Of Princeton University	6-alkenyl and ethynyl derivatives of 2-amino-4-hydroxypyrido[2,3-d]pyrimidines
US4921858A (en) *	1986-10-24	1990-05-01	Warner-Lambert Company	7-deazaguanines as immunomodulators
JP2830008B2 (ja) *	1988-04-01	1998-12-02	武田薬品工業株式会社	縮合ピリミジン誘導体
NO169490C (no) *	1988-03-24	1992-07-01	Takeda Chemical Industries Ltd	Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater
US4882333A (en) *	1988-05-25	1989-11-21	The Trustess Of Princeton University	N-(5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-yl-alkanoyl)-glutamic acid derivatives
CH677140A5 (fi) *	1988-10-11	1991-04-15	W & E Umwelttechnik Ag
AU641183B2 (en) *	1989-09-19	1993-09-16	Teijin Limited	Pyrrolo(2,3-d)pyrimidine derivative, process for preparing the same, and pharmaceutical preparation comprising the derivative as active ingredient
CA2032695A1 (en) *	1989-12-20	1991-06-21	Hiroshi Akimoto	Condensed heterocyclic compounds, their production and use

1992
- 1992-03-24 US US07/856,611 patent/US5196424A/en not_active Expired - Fee Related
1993
- 1993-03-18 CA CA002091978A patent/CA2091978A1/en not_active Abandoned
- 1993-03-18 NZ NZ247193A patent/NZ247193A/en unknown
- 1993-03-18 TW TW082101987A patent/TW224098B/zh active
- 1993-03-18 ZA ZA931944A patent/ZA931944B/xx unknown
- 1993-03-18 IL IL105100A patent/IL105100A0/xx unknown
- 1993-03-18 EP EP93302063A patent/EP0567223A1/en not_active Withdrawn
- 1993-03-18 MY MYPI93000474A patent/MY131322A/en unknown
- 1993-03-18 CZ CZ93440A patent/CZ44093A3/cs unknown
- 1993-03-19 MX MX9301544A patent/MX9301544A/es unknown
- 1993-03-19 NO NO93931008A patent/NO931008L/no unknown
- 1993-03-19 HU HU9300804A patent/HUT70036A/hu unknown
- 1993-03-22 KR KR1019930004440A patent/KR930019676A/ko not_active Application Discontinuation
- 1993-03-22 FI FI931251A patent/FI931251L/fi not_active Application Discontinuation
- 1993-03-23 CN CN93103205A patent/CN1078235A/zh not_active Withdrawn
- 1993-03-23 AU AU35429/93A patent/AU3542993A/en not_active Abandoned
- 1993-03-23 BR BR9301273A patent/BR9301273A/pt not_active Application Discontinuation
- 1993-03-23 JP JP5063819A patent/JPH0625246A/ja active Pending

Also Published As

Publication number	Publication date
HU9300804D0 (en)	1993-06-28
BR9301273A (pt)	1993-09-28
NZ247193A (en)	1995-05-26
CA2091978A1 (en)	1993-09-25
NO931008L (no)	1993-09-27
IL105100A0 (en)	1993-12-28
MY131322A (en)	2007-08-30
US5196424A (en)	1993-03-23
HUT70036A (en)	1995-09-28
AU3542993A (en)	1993-09-30
NO931008D0 (no)	1993-03-19
FI931251A0 (fi)	1993-03-22
EP0567223A1 (en)	1993-10-27
TW224098B (fi)	1994-05-21
MX9301544A (es)	1994-07-29
CN1078235A (zh)	1993-11-10
KR930019676A (ko)	1993-10-18
CZ44093A3 (en)	1994-02-16
ZA931944B (en)	1994-09-18
JPH0625246A (ja)	1994-02-01

Publication	Publication Date	Title
FI932445L (fi)	1993-11-30	Farmaceutiska foereningar
NO942923L (no)	1994-08-05	Medikamenter
FI930882A (fi)	1993-08-29	Farmaceutiska foereningar
FI911986L (fi)	1991-10-26	Farmaceutiska foereningar.
FI951098L (fi)	1995-03-09	Farmaseuttinen pakkaus
FI924340L (fi)	1992-09-28	Farmaceutiska beredningar
NO954146D0 (no)	1995-10-18	Belagte farmasöytiske preparater
BR1100824A (pt)	1999-08-31	Composto e composição farmacêutica
FI921060L (fi)	1992-09-15	Farmaceutiska aerosolformuleringar
NO923127D0 (no)	1992-08-11	Farmasoeytisk kombinasjonsformulering
NO923859D0 (no)	1992-10-02	Medikament
NO931831D0 (no)	1993-05-19	Farmasoeytiske blandinger
FI935584L (fi)	1995-06-14	Farmaseuttinen granulaatti
FI935065L (fi)	1994-05-19	Farmaceutiska foereningar
FI931251L (fi)	1993-09-25	Farmaceutiska foereningar
FI955605A0 (fi)	1995-11-21	Aryloivia lääkkeitä
DK86492D0 (da)	1992-06-30	Laegemiddel
FI921877L (fi)	1992-10-30	Farmaceutiska foereningar
NO961589D0 (no)	1996-04-19	Farmasöytiske blandinger
FI930128L (fi)	1993-07-15	Doseringslist
FI934387A0 (fi)	1993-10-06	3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
FI923869L (fi)	1993-03-06	Farmaceutiska aemnen
FI934317A0 (fi)	1993-10-01	Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen
ATA83492A (de)	1994-05-15	Zerstörladung
NO920039D0 (no)	1992-01-02	Farmasoeytiske preparater

Legal Events

Date	Code	Title	Description
1996-06-27	FD	Application lapsed